fluoxetine has been researched along with Kidney Failure, Chronic in 7 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Guidelines suggest treatment of depression in dialysis patients with pharmacological therapy, preferably a selective serotonin reuptake inhibitor." | 2.53 | Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. ( Craig, JC; Natale, P; Palmer, SC; Rabindranath, KS; Ruospo, M; Saglimbene, VM; Strippoli, GF, 2016) |
| "Nonsudden cardiac death was treated as a competing event." | 1.51 | Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. ( Assimon, MM; Brookhart, MA; Flythe, JE, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ratnapala, US | 1 |
| Yucel-Finn, A | 1 |
| Walbaum, D | 1 |
| Dempsey, O | 1 |
| Assimon, MM | 1 |
| Brookhart, MA | 1 |
| Flythe, JE | 1 |
| Palmer, SC | 1 |
| Natale, P | 1 |
| Ruospo, M | 1 |
| Saglimbene, VM | 1 |
| Rabindranath, KS | 1 |
| Craig, JC | 1 |
| Strippoli, GF | 1 |
| Finkelstein, FO | 1 |
| Watnick, S | 1 |
| Finkelstein, SH | 1 |
| Wuerth, D | 1 |
| Levy, NB | 2 |
| Blumenfield, M | 2 |
| Beasley, CM | 2 |
| Dubey, AK | 2 |
| Solomon, RJ | 2 |
| Todd, R | 2 |
| Goodman, A | 2 |
| Bergstrom, RR | 1 |
| Spinowitz, B | 1 |
| Charytan, C | 1 |
| Bergstrom, RF | 1 |
| Luft, FC | 1 |
| Aronoff, GR | 1 |
| Sloan, RS | 1 |
| Fineberg, NS | 1 |
2 reviews available for fluoxetine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Fluoxetine; Humans; Kidney Failure, Chronic; P | 2016 |
The treatment of depression in patients maintained on dialysis.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Fluoxetine; Humans; Kidney Failu | 2002 |
1 trial available for fluoxetine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Fluoxetine in depressed patients on dialysis.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Meth | 1997 |
4 other studies available for fluoxetine and Kidney Failure, Chronic
| Article | Year |
|---|---|
A puzzling pneumonia in a young immunosuppressed man.
Topics: Adult; Depressive Disorder; Diagnosis, Differential; Fluoxetine; Humans; Immunocompromised Host; Kid | 2018 |
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, | 2019 |
Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationsh | 1996 |
Intra- and interindividual variability in sodium intake in normal subjects and in patients with renal insufficiency.
Topics: Adolescent; Adult; Creatinine; Electrolytes; Fluoxetine; Homeostasis; Humans; Kidney Failure, Chroni | 1986 |